Erratum: The effects of an anabolic agent on body composition and pulmonary function in tetraplegia: A pilot study (Spinal Cord (2009) DOI: 10.1038/sc.2009.82);The effects of an anabolic agent on body composition and pulmonary function in tetraplegia: A pilot study

Spinal Cord

Volumn 48, Issue 1, 2010, Pages 55-59

  Halstead, L S ^a   Groah, S L ^a   Libin, A ^a   Hamm, L F ^b   Priestley, L ^a  

^a NATIONAL REHABILITATION HOSPITAL   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anabolic steroid; Body composition; Obesity; Pulmonary function; Spinal cord injury; Tetraplegia

Indexed keywords

ANABOLIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXANDROLONE;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; LIVER FUNCTION TEST; LONGITUDINAL STUDY; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUADRIPLEGIA; RISK FACTOR; SIDE EFFECT; TREATMENT DURATION;

EID: 75149182735     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2009.129     Document Type: Erratum

References (25)

1. Guttman L. Spinal Cord Injuries: Comprehensive Management and Research, 2nd edn. Blackwell Scientific Publications: London, 1976.
2. Castro MJ, Apple Jr DF, Staron RS, Campos GE, Dudley GA. Influence of complete spinal cord injury on skeletal muscle within 6 mo of injury. J Appl Physiol 1999; 86: 350-358.
3. Wilmet E, Ismail AA, Heilporn A, Welraeds D, Bergmann P. Longitudinal study of the bone mineral content and of soft tissue composition after spinal cord section. Paraplegia 1995; 33: 674-677.
4. Cardus D, McTAggart WG. Body composition in spinal cord injury. Arch Phys Med Rehabil 1985; 66: 257-259.
5. Spungen AM, Adkins RH, Stewart CA. Factors influencing body composition in persons with spinal cord injury: a cross-sectional study. J Appl Physiol 2003; 95: 2398-2407.
6. Linn WS, Spungen AM, Gong Jr H, Adkins RH, Bauman WA, Waters RL. Forced vital capacity in two large outpatient populations with chronic spinal cord injury. Spinal Cord 2001; 39: 263-268.
7. Baydur A, Adkins RH, Milic-Emili J. Lung mechanics in individuals with spinal cord injury: effects of injury level and posture. J Appl Physiol 2001; 90: 405-411.
8. Frankel HL, Coll JR, Charlifue SW, Whiteneck GG, Gardner BP, Jamous MA et al. Long-term survival in spinal cord injury: a fifty year investigation. Spinal Cord 1998; 36: 266-274.
9. McKinley WO, Jackson AB, Cardenas DD, DeVivo MJ. Long-term medical complications after traumatic spinal cord injury: a regional model systems analysis. Arch Phys Med Rehabil 1999; 80: 1402-1410.
10. Abrams D. Use of androgens in patients who have HIV/AIDS: what we know about the effect of androgens on wasting and lipodystrophy. AIDS Read 2001; 11: 149-156.
11. Jeschke MG, Finnerty CC, Suman OE, Kulp G, Mlcak RP, Herndon DN. The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg 2007; 246: 351-360.
12. Sharma S, Arneja A, McLean L, Duerksen D, Leslie W, Sciberras D et al. Anabolic steroids in COPD: a review and preliminary results of a randomized trial. Chron Respir Dis 2008; 5: 169-176.
13. Spungen AM, Koehler KM, Modeste-Duncan R, Rasul M, Cytryn AS, Bauman WA. 9 clinical cases of nonhealing pressure ulcers in patients with spinal cord injury treated with an anabolic agent: a therapeutic trial. Adv Skin Wound Care 2001; 14: 139-144.
14. Spungen AM, Grimm DR, Strakhan M, Pizzicato PM, BaumanWA. Treatment with an anabolic agent is associated with improvement in respiratory function in persons with tetraplegia: a pilot study. Mt Sinai J Med 1999; 66: 201-205.
15. American Spinal Injury Association. International Standards for Neurological Classification of Spinal Cord Injury, Revised 2002. American Spinal Injury Association: Atlanta, 2002.
16. National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. National Institutes for Health: Bethesda, MD, 1998. NIH publication No. 98-4083.
17. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
18. Pithon KR, Martins LEB, Renno ACM, Abreu DC, Cliquet Jr A. Pulmonary function testing in quadriplegic subjects. Spinal Cord 2008; 46: 275-277.
19. Gater DR. Obesity after spinal cord injury. Phys Med Rehabil Clin N Am 2007; 18: 333-351.
20. Rajan S, McNeely MJ, Warms C, Goldstein B. Clinical assessment and management of obesity in individuals with spinal cord injury. J Spinal Cord Med 2008; 31: 361-372.
21. Jones LM, Legge M, Goulding A. Healthy body mass index values often underestimate body fat in men with spinal cord injury. Arch Phys Med Rehabil 2003; 84: 1068-1071.
22. Buchholz AC, McGillivrary CF, Pencharz PB. Differences in resting metabolic rate between paraplegic able-bodied subjects are explained by differences in body composition. Am J Clin Nutr 2003; 77: 371-378.
23. Gater D, Clasey J. Body composition assessment in spinal cord injury clinical trials. Top Spinal Cord Inj Rehabil 2006; 11: 36-49.
24. Olda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 2008; 31: 1283-1291. Review.
25. Holt RI. International Diabetes Federation re-defines the metabolic syndrome. Diabetes Obes Metab 2005; 7: 618-620.